Antibe Therapeutics Inc. announced the appointment of Amal Khouri (B.Sc., MBA) to its board of directors, effective immediately. Ms. Khouri brings extensive pharmaceutical business development experience to the company and succeeded Samira Sakhia as of March 19, 2018. Ms. Khouri has more than 15 years of business development experience in the pharmaceutical industry and is presently Vice President of Business Development at Knight Therapeutics Inc. (“Knight”). Prior to Knight, Ms. Khouri worked at Novartis Pharma for over 7 years, where she held multiple positions within the global business development and licensing team in Basel, Switzerland. Before joining Novartis, she worked in business development at Paladin Labs in roles with increasing responsibilities.